Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Greil

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Leukemia Research|May 24, 2017
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experienceM Leisch, L Weiss, N Lindlbauer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2001
Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2I Tinhofer, D Bernhard, M Senfter, et al.
British Journal of Haematology|April 1, 1993
Extensive meningeal involvement as the primary manifestation of a systemic small lymphocytic lymphoma: favourable outcome after neuraxial irradiation without chemotherapyD Soucek, G Ransmayr, K Twerdy, et al.
British Journal of Haematology|September 12, 1998
Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevityA Villunger, A Egle, M Kos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphomaL Weiss, T Melchardt, S Habringer, et al.
Blood|July 1, 1997
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillanceA Villunger, A Egle, I Marschitz, et al.
FEBS Letters|January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsS Geley, B L Hartmann, K Kapelari, et al.
Leukemia|May 21, 2014
APOBEC3 signature mutations in chronic lymphocytic leukemiaS Rebhandl, M Huemer, F J Gassner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label studyR von Moos, C B Caspar, B Thürlimann, et al.
Leukemia|May 25, 2011
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLLJ Piñón Hofbauer, C Heyder, U Denk, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Leukemia Research|May 24, 2017
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experienceM Leisch, L Weiss, N Lindlbauer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2001
Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2I Tinhofer, D Bernhard, M Senfter, et al.
British Journal of Haematology|April 1, 1993
Extensive meningeal involvement as the primary manifestation of a systemic small lymphocytic lymphoma: favourable outcome after neuraxial irradiation without chemotherapyD Soucek, G Ransmayr, K Twerdy, et al.
British Journal of Haematology|September 12, 1998
Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevityA Villunger, A Egle, M Kos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphomaL Weiss, T Melchardt, S Habringer, et al.
Blood|July 1, 1997
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillanceA Villunger, A Egle, I Marschitz, et al.
FEBS Letters|January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsS Geley, B L Hartmann, K Kapelari, et al.
Leukemia|May 21, 2014
APOBEC3 signature mutations in chronic lymphocytic leukemiaS Rebhandl, M Huemer, F J Gassner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label studyR von Moos, C B Caspar, B Thürlimann, et al.
Leukemia|May 25, 2011
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLLJ Piñón Hofbauer, C Heyder, U Denk, et al.
Pageof 15